Lilly Ventures is the venture capital arm of Eli Lilly and Company responsible for life science investing in North America and Europe.  Our primary goal is to facilitate the success of companies in our areas of focus through early to expansion stage investments and value-adding resources.

Lilly Ventures currently has $200 million under management and focuses on three major areas of interest.

Investment Focus

Biotechnology: targeting investments in biotechnology companies that leverage proprietary drug discovery or development technologies to build a multi-product pipeline.

Medical Technology: targeting investments in companies focusing on the convergence of pharmaceuticals, devices or diagnostics.

Healthcare IT: targeting investments in expansion stage companies with innovative network technologies that promise to have a transformational impact on the current pharmaceutical business model.

Our investment approach centers on working with superior management teams to help them realize the financial potential of their ideas.  Accordingly, we provide both financial and intellectual resources to accelerate the management teams’ path to success.

Our sister fund, Lilly Asian Ventures, was established in 2007 with a geographic focus on the emerging life science businesses of east and south Asia, particularly China and India. To learn more, please go to www.lillyasianventures.com.

Value-Added Resources

Access to industry knowledge and contacts
Through our affiliation with Eli Lilly and Company, Lilly Ventures provides our portfolio companies with access to the collective knowledge and contact base generated by Lilly’s world-class scientists, experienced clinical investigators and respected sales and marketing professionals.

Product insights
Our affiliation with Eli Lilly and Company also greatly enhances our ability to evaluate new technologies and therapies from a customer or prospective partner perspective.

Strategic relationships
Through our collaborations with industry experts, the venture capital industry and investment banks, we tap into a global network of contacts to assist portfolio companies with various aspects of growing their business.

Operational focus
With one primary source of funds, Lilly Ventures is able to concentrate all our efforts and resources on evaluating business concepts and generating long-term capital gain, for our portfolio companies and other investors.